Levin Capital Strategies’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,071	Closed	-$448K	–	257
2024 Q1	$448K	Sell	1,071 -550	-34%	-$230K	0.04%	133
2023 Q4	$660K	Buy	+1,621	New	+$660K	0.07%	103